Symmetry Partners, LLC Charles River Laboratories International, Inc. Transaction History

Symmetry Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	SELL	$204.13 - $302.4 $37,151 - $55,036	-182 Reduced 10.72%	1,515 $324,000
Q4 2021 Jan 11, 2022	SELL	$351.38 - $448.68 $107,522 - $137,296	-306 Reduced 15.28%	1,697 $639,000
Q4 2020 Feb 18, 2021	BUY	$222.0 - $252.62 $99,012 - $112,668	446 Added 28.64%	2,003 $500,000
Q3 2020 Nov 03, 2020	BUY	$175.56 - $226.45 $273,346 - $352,582	1,557 New	1,557 $353,000
Q3 2019 Nov 04, 2019	SELL	$125.07 - $143.67 $262,897 - $301,994	-2,102 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$123.4 - $148.55 $91,933 - $110,669	745 Added 54.9%	2,102 $298,000
Q1 2019 May 13, 2019	BUY	$104.82 - $146.73 $86,476 - $121,052	825 Added 155.08%	1,357 $197,000
Q4 2018 May 22, 2019	BUY	$105.09 - $137.23 $55,907 - $73,006	532 New	532 $60,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.96B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Symmetry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Symmetry Partners, LLC with notifications on news.